Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| TScan Therapeutics, Inc.(TCRX) | 630,000 | 630,000 | 0 | $630.0K | $630.0K | 42.40% | $0 |
| Werewolf Therapeutics, Inc.(HOWL) | 589,102 | 589,102 | 0 | $373.2K | $490.5K | 33.01% | +$117.3K |
| Barinthus Biotherapeutics PlADS | 642,204 | 642,204 | 0 | $449.6K | $365.4K | 24.59% | -$84.2K |